Bill Nygren - Harris Associates L P
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2014 Q1 | 0 | 0.00 | Sell 100.00% | 0.42 | SEC | ||
| 2013 Q4 | 4,268,300 | 0.42 | Reduce 0.02% | <0.01 | $53.54 | $228,525,000 | SEC |
| 2013 Q3 | 4,269,300 | 0.53 | Reduce 0.13% | <0.01 | $61.79 | $263,800,000 | SEC |
| 2013 Q2 | 4,274,700 | 0.56 | Reduce 16.61% | 0.11 | $60.63 | $259,175,000 | SEC |
| 2013 Q1 | 5,126,400 | 0.66 | Reduce 11.29% | 0.09 | $56.45 | $289,385,000 | SEC |
| 2012 Q4 | 5,779,100 | 0.83 | Reduce 2.53% | 0.02 | $58.27 | $336,748,000 | SEC |
| 2012 Q3 | 5,928,900 | 0.96 | Reduce 5.25% | 0.05 | $63.43 | $376,070,000 | SEC |
| 2012 Q2 | 6,257,500 | 0.99 | Reduce 10.05% | 0.12 | $59.90 | $374,824,000 | SEC |
| 2012 Q1 | 6,956,842 | 1.19 | Reduce 3.95% | 0.06 | $61.25 | $426,108,000 | SEC |
| 2011 Q4 | 7,243,041 | 1.40 | Reduce 1.27% | 0.02 | $58.21 | $421,644,000 | SEC |
| 2011 Q3 | 7,336,125 | 1.34 | Add 6.65% | 0.08 | $49.82 | $365,466,000 | SEC |
| 2011 Q2 | 6,878,439 | 1.30 | Add 73.18% | 0.55 | $57.18 | $393,277,000 | SEC |
| 2011 Q1 | 3,971,953 | 0.78 | Add 28,892.36% | 0.78 | $58.66 | $232,999,000 | SEC |
| 2010 Q4 | 13,700 | <0.01 | Buy | <0.01 | $53.94 | $739,000 | SEC |